Pfizer-BioNTech launch trial of Omicron-targeted COVID-19 vaccine

Pfizer and BioNTech said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.

from CBC | Health News https://ift.tt/3qWZ7Ms